So Ken, being at sort of the home of PTsi, what are people looking at both in adults and in pediatrics in terms of enhancing the immune reconstitution, which I think those of us in the adult world still recognize as being a major problem with that regimen?

Well, I'm glad you brought that up, Corey.

I, I'd love to know what the, the published data are on this.

Uh, our data for immune reconstitution, particularly in the context of haploidentical transplants, although this has not been published, is actually quite robust.

I will tell you, certainly in the context of our non-malignant disorders, we really have no issues with immune reconstitution with respect to immunoglobulin levels, with respect to CD4 recovery.

And I, I am well aware of the data that have been, I, I think soon to be published by Leslie Keen and colleagues, which speak to this, quote, "bottleneck." I mean, I think that was very elegant work.

I would pause and say on record that God forbid I needed a transplant, I would really want to be alive, disease-free, and GVHD-free.

So Ken, what are you excited about on the PTsi side of things in terms of novel strategies there?